Top Markets
Coin of the day
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204
주식 순위 #7949
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical... Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
주가
$3.11
시가총액
$1.41B
변동 (1일)
-1.97%
변동 (1년)
-57.22%
국가
CN
거래 Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)

카테고리

Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)의 주식 분할 이력
Staidson (Beijing) BioPharmaceuticals Co., Ltd. 주식 (심볼: 300204)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 28, 2026에 발생했습니다.
Aug 28, 2026 이전에 매수한 300204 주식 1주는 현재 0주의 300204 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH